RT Journal Article
SR Electronic
T1 Autologous dendritic cell immunotherapy (DCVAC/PCa) added to docetaxel chemotherapy in a Phase III trial (viable) in men with advanced (mCRPC) prostate cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP P164
DO 10.1186/2051-1426-3-S2-P164
VO 3
IS Suppl 2
A1 Beer, Tomasz M
A1 Vogelzang, Nicholas
A1 Bartůňková, Jiřina
A1 Miller, Kurt
A1 Oh, William
A1 Oudard, Stephane
A1 Pandha, Hardev
A1 Sartor, A Oliver
A1 Špíšek, Radek
A1 Toole, Timothy O
A1 Borgstein, Niels G
A1 Gerritsen, Winald R
YR 2015
UL http://jitc.bmj.com/content/3/Suppl_2/P164.abstract